PRS
NVO

Pinkerton Retirement Specialists’s Novo Nordisk NVO Stock Holding History

Pinkerton Retirement Specialists’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,247
Closed -$2.17M – 137
2024
Q4 		$2.17M Buy
25,247
+317
+1% +$34.3K 0.32% 74
2024
Q3 		$2.97M Buy
24,930
+367
+1% +$48.9K 0.43% 63
2024
Q2 		$3.51M Sell
24,563
-157
-0.6% -$20.8K 0.54% 57
2024
Q1 		$3.17M Sell
24,720
-790
-3% -$94K 0.51% 58
2023
Q4 		$2.64M Sell
25,510
-2,756
-10% -$273K 0.51% 47
2023
Q3 		$2.57M Buy
28,266
+1,424
+5% +$125K 0.56% 47
2023
Q2 		$2.17M Sell
26,842
-670
-2% -$54.7K 0.43% 67
2023
Q1 		$2.19M Buy
+27,512
New +$1.95M 0.41% 68
2017
Q1 		– Sell
-15,908
Closed -$285K – 382
2016
Q4 		$285K Sell
15,908
-962
-6% -$17.4K 0.13% 72
2016
Q3 		$351K Buy
16,870
+3,346
+25% +$83K 0.15% 87
2016
Q2 		$364K Buy
+13,524
New +$371K 0.18% 63

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pinkerton Retirement Specialists's NVO Position: Q1 2025 in Review

Pinkerton Retirement Specialists sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 25,247 shares — an estimated $2.17M sold.

Pinkerton Retirement Specialists first reported a position in NVO in Q2 2016 and held it in 11 quarters. The position peaked at $3.51M in Q2 2024. 1,531 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Pinkerton Retirement Specialists reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 25,247 Novo Nordisk shares in Q1 2025, an estimated $2.17M.
  • Pinkerton Retirement Specialists first reported a position in Novo Nordisk in Q2 2016 and held it in 11 quarters.
  • Pinkerton Retirement Specialists's Novo Nordisk position peaked at $3.51M in Q2 2024.
  • 1,531 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2025, filed 2 May 2025.